| __timestamp | Incyte Corporation | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 347523000 | 85181000 |
| Thursday, January 1, 2015 | 479514000 | 135253000 |
| Friday, January 1, 2016 | 581861000 | 162297000 |
| Sunday, January 1, 2017 | 1326361000 | 198442000 |
| Monday, January 1, 2018 | 1197957000 | 226616000 |
| Tuesday, January 1, 2019 | 1154111000 | 299726000 |
| Wednesday, January 1, 2020 | 2215942000 | 335375000 |
| Friday, January 1, 2021 | 1458179000 | 505748000 |
| Saturday, January 1, 2022 | 1585936000 | 590453000 |
| Sunday, January 1, 2023 | 1627594000 | 849658000 |
| Monday, January 1, 2024 | 2606848000 |
Unleashing the power of data
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Incyte Corporation and Jazz Pharmaceuticals plc have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Incyte Corporation's R&D expenses surged by over 360%, peaking in 2020 with a remarkable 2.2 billion dollars. This aggressive investment reflects Incyte's dedication to expanding its drug pipeline and enhancing its market position.
Conversely, Jazz Pharmaceuticals plc exhibited a more conservative growth in R&D spending, increasing by approximately 900% over the same period. Despite this slower pace, Jazz's strategic investments have enabled it to maintain a steady flow of innovative treatments. As the biopharmaceutical landscape continues to evolve, these companies' R&D strategies will play a crucial role in shaping their future success.
Analyzing R&D Budgets: Novo Nordisk A/S vs Incyte Corporation
R&D Spending Showdown: Bristol-Myers Squibb Company vs Jazz Pharmaceuticals plc
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Incyte Corporation
Teva Pharmaceutical Industries Limited vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Insights: How United Therapeutics Corporation and Incyte Corporation Allocate Funds
Incyte Corporation vs Alkermes plc: Strategic Focus on R&D Spending
Incyte Corporation vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Jazz Pharmaceuticals plc vs Viking Therapeutics, Inc.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs CRISPR Therapeutics AG
Research and Development Investment: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.